• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Systemic Immune Cell Changes in Non-Ischemic Heart Failure Spare Cardiac Tissue

by
November 20, 2026
in Health
Reading Time: 6 mins read
0
Systemic Immune Cell Changes in Non-Ischemic Heart Failure Spare Cardiac Tissue

Systemic Immune Cell Changes in Non-Ischemic Heart Failure Spare Cardiac Tissue

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In an extensive investigation of immune system alterations in cardiovascular disease, researchers have uncovered pronounced systemic immune remodeling and features of immunosenescence in patients with non-ischemic heart failure, occurring without overt leukocyte infiltration in cardiac tissue. Published in the journal Immunity and Ageing, the investigation led by Lukas Baumhove, Gwenny M.P.J. Verstappen, and colleagues evaluated cellular phenotypes and effector functions to address an unresolved knowledge gap in non-ischemic cardiomyopathy. Although heart failure has long been linked to chronic low-grade systemic inflammation and adverse myocardial remodeling, translating immunological insights into effective therapies has remained elusive. Most established treatments continue to focus on neurohormonal, hemodynamic, and metabolic pathways rather than immune mechanisms. While earlier work focused primarily on ischemic injuries such as myocardial infarction, this study systematically characterized peripheral blood mononuclear cells and paired myocardial tissue biopsies to determine how circulating immune changes manifest systemically and locally in patients with dilated cardiomyopathy.

The clinical investigation examined peripheral blood mononuclear cells isolated from nineteen patients presenting with non-ischemic heart failure due to dilated cardiomyopathy and nineteen control individuals without heart failure. The control group was selected from a previously established cohort of elderly participants without heart failure, enabling researchers to compare pathological immune alterations against baseline age-related characteristics. To eliminate major confounding influences on immune status, neither patients nor controls received immunosuppressive medications or had ongoing acute infections. In addition to peripheral blood sampling, researchers obtained apical left ventricular myocardial tissue samples from seven of the included heart failure patients during left ventricular assist device implantation. For histological comparison, left ventricular tissue was procured from four healthy donor hearts that could not be transplanted for logistical reasons, with all procedures approved by the institutional review board of the University Medical Center Groningen.

To evaluate leukocyte phenotypes, the team conducted multiparametric spectral flow cytometry using Cytek Aurora and BD FACSymphony cytometers on cryopreserved peripheral blood mononuclear cells. Following thawing in Roswell Park Memorial Institute 1640 medium supplemented with ten percent fetal calf serum, cells were divided across five flow cytometry experiments. These assays encompassed the phenotyping of monocytes and dendritic cells, senescence markers on monocytes, T-cell surface receptors, intracellular cytokine expression in T-cells, and cytokine production in stimulated monocytes. Cytometer setup and tracking beads ensured standardization across measurement sessions, with gating thresholds established using fluorescence-minus-one and biological negative controls. Cell viability was determined using propidium iodide and fixable viability dyes. In the T-cell intracellular assay, cells were stimulated with phorbol 12-myristate 13-acetate and calcium ionophore A23187 in the presence of brefeldin A before fixation and permeabilization, while monocyte stimulation utilized lipopolysaccharide and protein transport inhibition alongside Fc receptor blocking.

Flow cytometric analysis demonstrated a relative increase in total circulating monocytes among heart failure patients compared to controls. When evaluating specific monocyte subsets, researchers detected a significant reduction in the proportion of non-classical monocytes, identified by an absence of CD14 expression alongside CD16 positivity. In contrast, the proportions of classical monocytes bearing CD14 without CD16 and intermediate monocytes expressing both CD14 and CD16 showed no significant differences between the two groups. Because non-classical monocytes are involved in maintaining endothelial integrity and resolving tissue inflammation, their depletion indicates potential impairment in vascular homeostatic maintenance. Furthermore, correlation analyses demonstrated that lower frequencies of circulating non-classical monocytes correlated positively with reduced left ventricular ejection fraction, whereas classical monocyte frequencies correlated negatively with left ventricular ejection fraction. However, neither monocyte subset exhibited a significant correlation with circulating levels of N-terminal pro-B-type natriuretic peptide, demonstrating a selective association between monocyte subset redistribution and ventricular mechanical performance.

Surface marker characterization revealed distinct alterations in pattern recognition receptors and immune checkpoint molecules on circulating monocytes in heart failure patients. Surface expression of Toll-like receptor 4 was significantly elevated on intermediate and non-classical monocytes compared to controls, whereas expression levels of Toll-like receptor 2 and the costimulatory marker CD86 were comparable across all monocyte subsets. Simultaneously, all monocyte subsets in heart failure patients exhibited elevated expression of programmed death-ligand 1, while non-classical monocytes displayed an additional significant increase in programmed death-ligand 2 expression. Toll-like receptor 4 serves as a primary sensor for both microbial products and endogenous damage-associated molecular patterns released during tissue stress, indicating ongoing innate immune activation. Meanwhile, the observed upregulation of programmed death-ligand molecules represents an important immunosuppressive checkpoint mechanism. Because the programmed death-1 pathway is linked to the accumulation of senescent cells and chronic inflammatory states, these surface marker changes provide evidence of concurrent immune activation and features of immunosenescence.

To determine whether these surface receptor alterations influenced cellular cytokine production, researchers tested monocyte effector function through ex vivo lipopolysaccharide stimulation assays in a subset of participants. Following exposure to Escherichia coli-derived lipopolysaccharide for three and a half hours, intracellular accumulation of inflammatory cytokines was measured using flow cytometry. The production of interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha remained comparable between heart failure patients and control participants. Despite the observed upregulation of surface Toll-like receptor 4 and inhibitory checkpoint ligands, circulating monocytes maintained standard cytokine production profiles rather than exhibiting an exaggerated pro-inflammatory response or profound functional exhaustion. These findings demonstrate that basic inflammatory cytokine secretion is preserved in peripheral monocytes during non-ischemic heart failure.

In addition to monocyte remodeling, the investigation identified marked expansions across circulating dendritic cell populations in patients with non-ischemic heart failure. Total dendritic cell frequencies among peripheral blood mononuclear cells were substantially higher in heart failure patients than in healthy controls. This elevation was consistently observed across all three evaluated dendritic cell subsets, including plasmacytoid dendritic cells, conventional dendritic cell type 1, and conventional dendritic cell type 2. Dendritic cells serve as vital coordinators of innate and adaptive immune signaling, directing antigen presentation and regulating monocyte and macrophage homeostasis in cardiovascular disease models. Experimental literature suggests that conventional dendritic cell subsets contribute to myocardial inflammatory balance, while dendritic cells broadly participate in recruiting and activating T-lymphocytes. The widespread increase in circulating dendritic cells observed in this study extends earlier animal and acute clinical findings to the systemic circulation of non-ischemic heart failure patients, pointing toward sustained peripheral immune mobilization.

Detailed profiling of the adaptive immune compartment revealed a significant polarization within circulating CD4-positive T-helper lymphocyte populations. Heart failure patients exhibited a significant reduction in regulatory T-cells, defined as CD25-positive and CD127-low or negative, which are critical for maintaining immune tolerance and resolving inflammation. Concurrently, patients displayed a significant increase in CD4-positive effector T-cells, identified by CD45RO expression and CCR7 absence, alongside elevated frequencies of interleukin-17-producing Th17 cells. Conversely, granulocyte-macrophage colony-stimulating factor-producing CD4-positive T-cells were significantly reduced in heart failure patients. Frequencies of naive T-cells, central memory cells, and terminal effector memory cells showed no statistically significant differences between cohorts. Furthermore, CD4-positive T-cells producing interferon-gamma, interleukin-4, interleukin-10, and interleukin-21 remained unchanged. Because regulatory T-cells and Th17 cells share common differentiation requirements, an inflammatory environment can skew development toward Th17 cells at the expense of regulatory T-cells, creating a persistent pro-inflammatory state within circulating adaptive immunity.

To investigate whether systemic immune dysregulation reflected localized myocardial inflammation, the authors conducted histological and immunofluorescence analyses on left ventricular tissue from seven heart failure patients undergoing ventricular assist device implantation and four non-failing donor controls. Immunohistochemical staining evaluated CD3 for T-cells, CD68 for macrophages, and CD123 for plasmacytoid dendritic cells, alongside immunofluorescence targeting CD3, CD68, and CD11c. Microscopic evaluation revealed no overt immune cell infiltrates in the failing myocardial tissue, and no meaningful quantitative staining differences were detected between end-stage heart failure tissue and non-failing control tissue. Despite substantial differences in circulating immune cell populations, localized leukocyte infiltration was not evident in apical left ventricular samples. This observation aligns with spatial transcriptomic and immunofluorescence studies in other heart failure cohorts reporting normal myocardial immune cell abundance, reinforcing the finding that chronic systemic immune activation does not necessarily manifest as visible immune cell infiltration in end-stage ventricular myocardium.

The researchers highlighted several limitations inherent to their study design, including a modest sample size of nineteen patients and nineteen controls that limits statistical power and broad generalizability. Because the investigation evaluated associations, causal relationships between immune alterations and heart failure progression cannot be established. The control group, though exhibiting lower immune activation, was not age-matched and consisted of older individuals. Additionally, using cryopreserved cells may introduce isolation variability, while myocardial tissue analysis was limited to end-stage diseased explants and a targeted marker set, potentially missing low-grade or localized infiltration. Despite these constraints, the study provides a detailed characterization of systemic immune alterations in non-ischemic heart failure, documenting monocyte subset shifts, dendritic cell elevation, checkpoint upregulation, and T-cell imbalance without corresponding myocardial infiltration. These systemic patterns underscore the role of chronic immune dysregulation in non-ischemic disease and suggest potential therapeutic pathways, such as Toll-like receptor 4 inhibition, checkpoint modulation, and restoration of the regulatory T-cell and Th17 balance.

Subject of Research: Systemic immune cell alterations and myocardial infiltration in non-ischemic heart failure

Article Title: Immune cell signature in non-ischemic heart failure indicates chronic systemic immune activation with features of immunosenescence

Article References: Baumhove, L., Verstappen, G. M. P. J., Deiman, F. E., Dronkers, J., Abdulahad, W. H., van der Geest, K., Brouwer, E., Voors, A. A., van der Meer, P., & Bomer, N. (2026). Immune cell signature in non-ischemic heart failure indicates chronic systemic immune activation with features of immunosenescence. Immunity & Ageing, 23(1), Article 18. https://doi.org/10.1186/s12979-026-00568-6

Image Credits: AI Generated

DOI: 10.1186/s12979-026-00568-6

Keywords: non-ischemic heart failure, dilated cardiomyopathy, spectral flow cytometry, immunosenescence, monocyte subsets, non-classical monocytes, toll-like receptor 4, PD-L1 expression, PD-L2 expression, dendritic cells, plasmacytoid dendritic cells, conventional dendritic cells, regulatory T-cells, Th17 cells, left ventricular assist device, myocardial histology, lipopolysaccharide stimulation, left ventricular ejection fraction

News Source: Ophelia Keating. (November 20, 2026). Systemic Immune Cell Changes in Non-Ischemic Heart Failure Spare Cardiac Tissue. Scienmag.

Tags: conventional dendritic cellsdendritic cellsdilated cardiomyopathyimmunosenescenceleft ventricular assist deviceleft ventricular ejection fractionLipopolysaccharide stimulationmonocyte subsetsmyocardial histologynon-classical monocytesnon-ischemic heart failurePD-L1 expressionPD-L2 expressionplasmacytoid dendritic cellsregulatory T cellsspectral flow cytometryTh17 cellsToll-Like Receptor 4
Share12Tweet7Share2ShareShareShare1

Related Posts

Astrocytic Lipid Metabolism Regulates Brain Homeostasis and Fuels Progressive Neurodegeneration

Astrocytic Lipid Metabolism Regulates Brain Homeostasis and Fuels Progressive Neurodegeneration

November 20, 2026
One Third of Evaluated Turkish Ceramic Workers Diagnosed With Pneumoconiosis

One Third of Evaluated Turkish Ceramic Workers Diagnosed With Pneumoconiosis

November 20, 2026

Sensor Study Links Real-World Arm Movement to Post-Stroke Behavioral Factors

November 20, 2026

Thoracoscopic Surgery Resolves Rare Pulmonary Sequestration Presenting as Mediastinal Mass

November 20, 2026

POPULAR NEWS

  • Chemical and Microbial Feedback Loops Drive Soil Sickness in Medicinal Crops

    Chemical and Microbial Feedback Loops Drive Soil Sickness in Medicinal Crops

    29 shares
    Share 12 Tweet 7
  • National Survey Reveals Significant Digital Gaps Among Groups Facing Oral Health Inequities

    29 shares
    Share 12 Tweet 7
  • Review Evaluates Strategies to Prevent and Treat Mandibular Nerve Injury During Jaw Surgery

    29 shares
    Share 12 Tweet 7
  • Dental Sector Dominates Japan’s Regional Outpatient Dysphagia Rehabilitation Claims

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tigers and Leopards Coexist in Thailand by Staggering Activity Across Time

Astrocytic Lipid Metabolism Regulates Brain Homeostasis and Fuels Progressive Neurodegeneration

Holographic Model Shows Vanishing Scalar and Nonzero Tensor Monopole Cross Correlations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.